Inna Timofeeva

570 total citations
17 papers, 273 citations indexed

About

Inna Timofeeva is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Inna Timofeeva has authored 17 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Inna Timofeeva's work include Hematopoietic Stem Cell Transplantation (10 papers), Immune Cell Function and Interaction (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Inna Timofeeva is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Immune Cell Function and Interaction (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Inna Timofeeva collaborates with scholars based in Italy, Russia and United States. Inna Timofeeva's co-authors include Armando Santoro, Luca Castagna, Barbara Sarina, Stéfania Bramanti, Roberto Crocchiolo, Monica Balzarotti, Massimo Magagnoli, Enrico Lugli, Domenico Mavilio and Licia Siracusano and has published in prestigious journals such as Blood, British Journal of Cancer and Transfusion.

In The Last Decade

Inna Timofeeva

15 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inna Timofeeva Italy 10 126 126 81 65 56 17 273
Ayumi Numata Japan 11 97 0.8× 147 1.2× 76 0.9× 78 1.2× 53 0.9× 38 310
Jeremy Ramdial United States 10 129 1.0× 121 1.0× 63 0.8× 86 1.3× 37 0.7× 62 310
Geothy Chakupurakal Germany 12 126 1.0× 156 1.2× 157 1.9× 53 0.8× 31 0.6× 28 369
Warda Faridi United States 7 121 1.0× 76 0.6× 109 1.3× 61 0.9× 23 0.4× 13 257
Maite Encuentra Spain 9 162 1.3× 77 0.6× 84 1.0× 110 1.7× 59 1.1× 18 326
Cristina Castilla‐Llorente France 9 70 0.6× 106 0.8× 77 1.0× 65 1.0× 27 0.5× 40 260
Shin Young Hyun South Korea 10 86 0.7× 125 1.0× 65 0.8× 44 0.7× 71 1.3× 29 269
G Prentice Australia 7 103 0.8× 210 1.7× 85 1.0× 69 1.1× 70 1.3× 13 387
Izaskun Ceberio Spain 6 128 1.0× 127 1.0× 149 1.8× 64 1.0× 47 0.8× 9 280
Sheryl L. Asplund United States 12 98 0.8× 88 0.7× 62 0.8× 155 2.4× 33 0.6× 15 329

Countries citing papers authored by Inna Timofeeva

Since Specialization
Citations

This map shows the geographic impact of Inna Timofeeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inna Timofeeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inna Timofeeva more than expected).

Fields of papers citing papers by Inna Timofeeva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inna Timofeeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inna Timofeeva. The network helps show where Inna Timofeeva may publish in the future.

Co-authorship network of co-authors of Inna Timofeeva

This figure shows the co-authorship network connecting the top 25 collaborators of Inna Timofeeva. A scholar is included among the top collaborators of Inna Timofeeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inna Timofeeva. Inna Timofeeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Castagna, Luca, Inna Timofeeva, Stéfania Bramanti, et al.. (2021). Feasibility and Efficacy of CD45RA+ Depleted Donor Lymphocytes Infusion After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Patients With Hematological Malignancies. Transplantation and Cellular Therapy. 27(6). 478.e1–478.e5. 18 indexed citations
2.
Timofeeva, Inna. (2021). GEO-ECONOMIC SYSTEM AND STATE REGULATION OF ENTREPRENEURSHIP. Russian Journal of Management. 8(4). 56–60.
3.
Timofeeva, Inna, et al.. (2019). Interactive adaptation methods of students in modern university: best practices. 21(4). 93–98. 1 indexed citations
4.
Bramanti, Stéfania, Angela Nocco, Elisa Mauro, et al.. (2016). Desensitization with plasma exchange in a patient with human leukocyte antigen donor‐specific antibodies before T‐cell–replete haploidentical transplantation. Transfusion. 56(5). 1096–1100. 11 indexed citations
5.
Bramanti, Stéfania, Roberto Crocchiolo, Laura Giordano, et al.. (2016). Bone marrow donor‐related variables associated with harvest outcome inHLA‐haploidentical transplantation with postinfusion cyclophosphamide. Vox Sanguinis. 111(1). 93–100. 1 indexed citations
6.
Crocchiolo, Roberto, Stéfania Bramanti, Barbara Sarina, et al.. (2015). Infections after T‐replete haploidentical transplantation and high‐dose cyclophosphamide as graft‐versus‐host disease prophylaxis. Transplant Infectious Disease. 17(2). 242–249. 91 indexed citations
7.
Zucali, Paolo Andrea, Matteo Simonelli, Fabio De Vincenzo, et al.. (2012). Phase I and pharmacodynamic study of high-dose NGR–hTNF in patients with refractory solid tumours. British Journal of Cancer. 108(1). 58–63. 19 indexed citations
8.
Magagnoli, Massimo, Michele Spina, Monica Balzarotti, et al.. (2007). IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patients. Bone Marrow Transplantation. 40(11). 1019–1025. 15 indexed citations
9.
Todisco, Elisabetta, Luca Castagna, Barbara Sarina, et al.. (2007). CD34+ dose‐driven administration of granulocyte colony‐stimulating factor after high‐dose chemotherapy in lymphoma patients. European Journal Of Haematology. 78(2). 111–116. 4 indexed citations
10.
Castagna, Luca, Massimo Magagnoli, Monica Balzarotti, et al.. (2006). Tandem high‐dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: A monocenter prospective study. American Journal of Hematology. 82(2). 122–127. 22 indexed citations
11.
Siracusano, Licia, Monica Balzarotti, Massimo Magagnoli, et al.. (2004). FluCyD combination in low-grade lymphomas: An active regimen for selected patients. 7(3). 357–362. 1 indexed citations
12.
Bella, Silvia Della, Stefania Nicola, Inna Timofeeva, et al.. (2004). Are interleukin-16 and thrombopoietin new tools for the in vitro generation of dendritic cells?. Blood. 104(13). 4020–4028. 32 indexed citations
13.
Bertuzzi, Alexia, Luca Castagna, Vittorio Quagliuolo, et al.. (2003). Prospective study of high-dose chemotherapy and autologous peripheral stem cell transplantation in adult patients with advanced desmoplastic small round-cell tumour. British Journal of Cancer. 89(7). 1159–1161. 22 indexed citations
14.
Magagnoli, Massimo, Luca Castagna, Monica Balzarotti, et al.. (2003). Feasibility and toxicity of high‐dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non‐Hodgkin's lymphoma: Survey from a single institution. American Journal of Hematology. 73(4). 267–272. 11 indexed citations
15.
Castagna, Luca, Alexia Bertuzzi, Andrea Nozza, et al.. (2002). Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas. Bone Marrow Transplantation. 30(4). 207–214. 8 indexed citations
16.
Magagnoli, Massimo, Barbara Sarina, Monica Balzarotti, et al.. (2001). Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphoma. Bone Marrow Transplantation. 28(10). 923–927. 16 indexed citations
17.
Castagna, Luca, Andrea Nozza, Alexia Bertuzzi, et al.. (2001). Allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning in primary refractory prolymphocytic leukemia: graft-versus-leukemia effect without graft-versus-host disease. Bone Marrow Transplantation. 28(12). 1155–1156. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayumi Numata Breakdown of academic impact, for papers by Jeremy Ramdial Breakdown of academic impact, for papers by Geothy Chakupurakal Breakdown of academic impact, for papers by Warda Faridi Breakdown of academic impact, for papers by Maite Encuentra Breakdown of academic impact, for papers by Cristina Castilla‐Llorente Breakdown of academic impact, for papers by Shin Young Hyun Breakdown of academic impact, for papers by G Prentice Breakdown of academic impact, for papers by Izaskun Ceberio Breakdown of academic impact, for papers by Sheryl L. Asplund
Rankless by CCL
2026